NASDAQ: TRNSTranscat Inc Stock
$83.64+2.64 (+3.26%)
Updated Sep 16, 2026
TRNS Price
$83.64
Fair Value Price
$81.76
Market Cap
$782.85M
52 Week Low
$50.23
52 Week High
$100.00
P/E
226.05x
P/B
2.58x
P/S
2.48x
PEG
2.48x
Dividend Yield
N/A
Revenue
$348.40M
Earnings
$3.45M
Gross Margin
32.5%
Operating Margin
3.24%
Profit Margin
1%
Debt to Equity
0.63
Operating Cash Flow
$40M
Beta
0.94
Next Earnings
Nov 2, 2026
Ex-Dividend
N/A
Next Dividend
N/A
TRNS Overview
Transcat, Inc. is a provider of accredited calibration and laboratory instrument services, and a value-added distributor of professional grade test, measurement, and control instrumentation. The company operates through two segments, Service and Distribution, and focuses on providing services and products to highly regulated industries, particularly the life science industry, which includes pharmaceutical, biotechnology, and medical device businesses.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine TRNS's potential to beat the market
CHold
- Stocks with a Zen Rating of Hold (C) had an average return of +5.11% per year. Learn More
Zen Rating Component Grades
C
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Industrial Distribution
Industry Rating
B
TRNS
Ranked#14 of 17
Ranked#14 of 17
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $39.85 | A | |
| $183.54 | B | |
| $120.48 | B |
Be the first to know about important TRNS news, forecast changes, insider trades & much more!
TRNS News
Overview
Due Diligence Score
–
Industry Average (35)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how TRNS scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
TRNS ($83.64) is overvalued by 2.3% relative to our estimate of its Fair Value price of $81.76 based on Discounted Cash Flow (DCF) modelling
Below Fair Value Valuation
TRNS ($83.64) is not significantly undervalued (2.3%) relative to our estimate of its Fair Value price of $81.76 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
TRNS ($83.64) is trading above... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more TRNS due diligence checks available for Premium users.
Valuation
TRNS fair value
Fair Value of TRNS stock based on Discounted Cash Flow (DCF)
Price
$83.64
Fair Value
$81.76
Overvalued by
2.30%
TRNS ($83.64) is overvalued by... subscribe to Premium to read more.
Below Fair Value Valuation
TRNS ($83.64) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
TRNS ($83.64) is trading above... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
TRNS price to earnings (PE)
For valuing profitable companies with steady earnings
Company
226.05x
Industry
24.95x
Market
44.18x
TRNS is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
TRNS is poor value based... subscribe to Premium to read more.
P/E vs Market Valuation
TRNS price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
2.58x
Industry
5.45x
TRNS is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
TRNS price to earnings growth (PEG)
For valuing profitable companies with growth potential
TRNS is poor value relative... subscribe to Premium to read more.
PEG Value Valuation
TRNS's financial health
Profit margin
Revenue
$92.9M
Net Income
$1.3M
Profit Margin
1.4%
TRNS's Earnings (EBIT) of $11.28M... subscribe to Premium to read more.
Interest Coverage Financials
TRNS's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$492.6M
Liabilities
$189.7M
Debt to equity
0.63
TRNS's short-term assets ($95.73M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
TRNS's long-term liabilities ($151.31M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
TRNS's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
TRNS's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
$8.8M
Investing
-$16.8M
Financing
$9.7M
TRNS's operating cash flow ($40.04M)... subscribe to Premium to read more.
Debt Coverage Financials
TRNS vs Industrial Distribution Stocks
Transcat Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.